Most genetic or environmental factors work together in determining complex disease risk. Detecting gene-environment interactions may allow us to elucidate novel and targetable molecular mechanisms on how environmental exposures modify genetic effects. Unfortunately, standard logistic regression (LR) assumes a convenient mathematical structure for the null hypothesis that however results in both poor detection power and type 1 error, and is also susceptible to missing factor, imperfect surrogate, and disease heterogeneity confounding effects. Here we describe a new baseline framework, the asymmetric independence model (AIM) in case-control studies, and provide mathematical proofs and simulation studies verifying its validity across a wide range of conditions. We show that AIM mathematically preserves the asymmetric nature of maintaining health versus acquiring a disease, unlike LR, and thus is more powerful and robust to detect synergistic interactions. We present examples from four clinically discrete domains where AIM identified interactions that were previously either inconsistent or recognized with less statistical certainty.
Thus, we address the following question: under the null hypothesis that genetic or environmental factors act independently to determine health status, how should a baseline independence model be formulated to reflect the aforementioned asymmetric nature of healthy versus diseased?
We develop an asymmetric independence model (AIM) in case-control studies for modelling the null hypothesis that attempts to mimic a sensible biological principle 10 ( Fig. 1b,d ): given the independence of the marginal health status ('healthy' or 'diseased') determined probabilistically by the individual factors involved 11 , being totally 'healthy' requires the presence of all marginal 'healthy' statuses while being 'non-healthy' requires only at least one but not necessarily all marginal 'diseased' statuses. Fundamental to the success of our approach is that AIM mathematically conforms to this asymmetry by specifying being totally 'healthy' only if every acting factor maintains a marginal 'healthy' status, with the individual otherwise 'diseased' (Methods and Fig. 1d ). Accordingly, in AIM the log-probability of being totally 'healthy' is linear in the factors whose coefficients correspond to the logarithms of marginal 'healthy' probabilities, whereas the log-probability of having disease is nonlinear in these factors (Methods and Eq. 6). Thus, a plausible disease model (AIM) is inherently an asymmetric one, unlike LR. Moreover, AIM is consistent even when the aforementioned confounders are present, both theoretically and experimentally, as seen in the sequel.
Results
Validation of AIM on type 1 error using simulated datasets. In the Supplement (Appendix D), we show that for all scenarios the empirical type 1 error produced by AIM closely approximates the expected type 1 error, unlike LR. We also show for AIM that the Q-Q plot closely aligns with the diagonal line with no noticeable deviation even when the factors are correlated or imbalanced.
Comparative assessment of AIM on power of detecting interactions using simulated datasets.
For power considerations, we simulated a comprehensive set of scenarios to examine how various model settings affect the performance (Appendix D and E). In most of the experiments, the ground-truth interaction models were based on an LR model with non-zero multiplicative interaction terms (Appendix D and E). The reason for this design is to assure that the LR approach is matched perfectly to the ground-truth interaction model and to show that the unsatisfactory power of LR is not in any way attributed to the interaction terms but rather is due to the LR baseline model. Note that even though AIM is not matched to the (LR) ground-truth interaction model (see Methods), AIM is guaranteed to be more powerful to detect synergistic interactions as shown in our experimental results and newly proved theorems (Supplement, Appendix C.7). Also note that when the multiplicative www.nature.com/scientificreports www.nature.com/scientificreports/ interaction terms are used with full parameters, this gives the same 'saturated model' for both LR and AIM under the alternative hypothesis (Supplement, Appendix C.7.3). Because the interaction models are under the alternative hypothesis (e.g., based on a logistic regression model with a non-zero interaction term), the empirical power of AIM is directly, fairly compared with that of LR. In our assessment experiments, we use the same multiplicative interaction terms to model the interaction between factors (interaction effect) in both LR and AIM under the alternative hypothesis, and then test any significant deviation of the alternative model's likelihood from the baseline model's likelihood.
Experimental results for different sample sizes show that AIM consistently exhibits higher power than LR; that is, to achieve the same power, AIM requires much fewer samples compared to LR (Fig. 2b) . The relatively larger gain by AIM for smaller effect sizes with limited samples, which often occurs in real applications, is particularly beneficial ( Supplementary Fig. S6a-c) . Experimental results also show that AIM consistently produces higher power than LR with varying case-control ratio (Fig. 2c) , allele frequency (Fig. 2d) , and factor correlation (Fig. 2e) . Concerning the impact of main effect size (additive portion) (Fig. 2f) , we notice that AIM's power quickly increases while LR's power slightly decreases as the main effect size increases. These divergent trends may be expected because an interaction becomes more obvious when the main effect is accurately estimated by AIM. Moreover, it is practically advantageous that, to achieve both high sensitivity and specificity, AIM needs about half of the sample size required by LR (Fig. 2g) . We again emphasize that, in all of these comparisons, the same (1000) data set realizations, based on a ground-truth LR model with interaction terms, were used to assess power for both LR and AIM. Thus, there is a fair comparative assessment of power between AIM and LR.
We also tested AIM on existing simulation data derived from real single nucleotide polymorphism (SNP) study data, as part of the New York City Cancer Control Project. This data set was used in previous studies on interaction detection in genome-wide association studies 12, 13 . The data set includes sub-populations that possess one (or more) distinct interactions, with five interactions in total. The interaction models vary in the order of the interaction (up to 5-way interactions), genetic models, incomplete/complete penetrance, minor allele frequency, and marginal effects size. The interaction models jointly determine the disease status for each individual; thus, the disease status in this data set is generated in a fashion quite different from both the LR and AIM interaction models. Full details on this data set can be found in the literature 12 . Again, superior power of AIM is observed for this data set (Fig. 2h) .
Comparative assessment of AIM in the presence of confounders using simulated datasets.
Specificity in detecting interactions can be greatly hampered by missing factors, imperfect surrogates, and disease www.nature.com/scientificreports www.nature.com/scientificreports/ heterogeneity, where 'interaction' is most commonly defined as a departure from additivity in a linear baseline model in which these ('imperfect') factors act independently to determine the response (Fig. 1a,b) . We investigated the impact of such confounders on the type 1 error both theoretically (Methods) and experimentally ( Supplementary Fig. S4 ). Using extensive simulations with various model parameter combinations, we show that for all scenarios AIM maintains accurate and robust empirical type 1 error rates that match almost perfectly the theoretical significance level, in the presence of missing factors (Fig. 3a) , imperfect surrogates (Fig. 3b) , and disease heterogeneity (Fig. 3c) . In contrast, for the same experimental settings LR produces inflated type 1 error rates ( Fig. 3a-c ) attributable to its mathematical inconsistency (Appendix B), resulting in more unwanted false positives specifically with larger main effect sizes.
Application of AIM on real venous thrombosis dataset detects interaction between variants of factor V and prothrombin contributing to increased risk of venous thrombosis. As an example of gene-environment interaction, the synergistic influence of thrombophilic mutation (R506Q and G20210A) and oral contraceptive on venous thrombosis is well-established by multiple epidemiological studies (Table 1) , with an observed odds ratio of 27.4 compared to the additive effect odds ratio of 9.34 14, 15 . Mechanistically, R506Q substitution in factor V involves one of three sites that are cleaved by activated protein C, resulting in augmented generation of thrombin; and G20210A mutation in the 3′ untranslated region of the prothrombin gene is associated with producing thrombin and activating factor Va 16 . In addition, oral contraceptives have long been recognized as a risk factor for venous thrombosis, with significant effect on producing thrombin via decreasing factor V and increasing prothrombin. Our AIM analysis of this case confirms the synergistic interaction with a p-value of 6.2e-4, much more confidently than the p-value of 0.021 assessed by LR. This result confirms not only the previously reported synergistic interaction but also AIM's ability to detect it correctly and surely (Methods).
Application of AIM on real esophageal cancer dataset detects smoking-alcohol interaction contributing to increased risk of esophageal cancer. Epidemiological studies have shown the synergistic interplay of tobacco smoking and alcohol consumption on various cancers. Specifically, studies have shown that the combination of the two factors significantly increased esophageal cancer risk more than either of them separately, where alcohol may act as a cocarcinogen that enhances the carcinogenic effects of tobacco smoking 17, 18 . However, the previously reported findings were inconsistent in that the evidence was significant in women and in all subjects but not in men (Table 2) 18, 19 . Separately analyzing the groups of men, women, and all (Methods), AIM produces consistent evidence across these groups with p-values of 5.43e-6, 3.1e-3, and 2.11e-8, respectively. On the same dataset, contradictory results remain for LR (Methods).
Application of AIM on real esophageal cancer dataset detects ALDH2-alcohol interaction contributing to increased risk of esophageal cancer. Both the ALDH2 gene and alcohol consumption are known risk factors associated with esophageal cancer. Heavy alcohol consumption has been found to be a risk factor for esophageal cancer in many epidemiological studies 20 . When alcohol is metabolized in the liver, it is broken down to acetaldehyde, a carcinogen that binds to cellular protein and DNA. The ALDH2 protein is responsible for degrading the carcinogen, and a functional polymorphism in the ALDH2 gene significantly reduces such capacity 21 . We re-analyzed the data of ALDH2-alcohol interaction effect on esophageal cancer to reinterpret marginally significant ALDH2 and alcohol consumption on the basis of their synergistic effects (Fig. 4) . The significance www.nature.com/scientificreports www.nature.com/scientificreports/ assessed by AIM produces a p-value of 7.4e-6, compared to a p-value of 2.5e-3 with LR, an almost thousand-fold improvement (Methods).
Application of AIM on real bladder cancer dataset detects NAT2-smoking interaction contributing to increased risk of bladder cancer. Multiple carcinogens have been found in tobacco smoke, and these carcinogens may undergo both activation and de-toxification. The NAT2 gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine carcinogens. The association of the NAT2 slow acetylator with bladder risk, caused by the polymorphisms in the NAT2 gene, is quite well established 22 . We re-analyzed this bladder cancer dataset to confirm the NAT2-smoking interaction. The significance assessed by AIM produces a p-value of 0.0011, compared to a p-value of 0.015 with LR (Table 3) . Multiple previous studies have consistently shown the interaction between the NAT2 gene and smoking on bladder cancer, where such interaction is evident because the observed odds ratio is 2.89 while the odds ratio in the presence of both factors is predicted to be 1.69 by the multiplicative model (Methods).
Discussion
Detecting synergistic interactions among risk factors is a fundamental task in clinical and population research. Few previous studies have addressed the problem of detecting interaction among known genetic or environmental factors 3 , and without exception, they adopt the LR framework [3] [4] [5] . However, while hypothesis testing using LR with interaction terms is a convenient solution and is widely used in practice, the LR framework is poorly powered and ill-suited under several commonly occurring circumstances, including missing or unmeasured risk factors, imperfectly correlated surrogates, and multiple disease sub-types. The weakness of LR in these settings stems from the way the null hypothesis is defined (Appendix B).
In this report we propose the AIM framework as a biologically-inspired alternative to LR, based on the key observation that the mechanisms associated with acquiring a "disease" versus maintaining "health" are asymmetric. We have shown that AIM analysis on benchmark real datasets not only more confidently confirms known interactions but also successfully reconciles inconsistent interactions. Across all of our real data set experiments, AIM demonstrated enhanced power compared to LR. We further checked the types of interactions and found that they are all synergistic -in all of these applications, carrying double risk factors engendered larger risk than expected based just on additive effects. Supported theoretically by newly proved theorems and experimentally by comprehensive simulation studies, we conclude that the extra power and robust specificity gained by AIM relative to that of LR is attributable to two properties rooted in the AIM formulation: its asymmetry and mathematical consistency. To the best of our knowledge, AIM represents the first model that mathematically preserves the Table 2 . Joint association of alcohol drinking and tobacco smoking statuses with esophageal cancer risk. Table 3 . Joint association of tobacco smoking status and NAT2 acetylation genotype with bladder cancer risk.
www.nature.com/scientificreports www.nature.com/scientificreports/ asymmetry between being totally 'healthy' and 'non-healthy' 10 and explicitly relates its model coefficients to marginal 'healthy' probabilities. As a result, AIM guarantees a larger likelihood difference for synergistic interactions under alternative versus null hypotheses than that of LR (Appendix C-E).
Methods

LR overview.
Baseline LR posits a log-linear odds in terms of the posterior probability on healthy/diseased status, i.e.,
where x is the vector of N binary health status variables, and α is the vector of regression coefficients. In our discussion, 'x i = 1' means that the ith disease factor is active, and 'x i = 0' means that the ith disease factor is inactive. By some simple mathematical manipulations, LR can also be expressed as
Because LR is adopted mainly for mathematical convenience but not biological plausibility, the vital and statistical relationship between the marginal | P x (healthy ) i LR and the overall |x P (healthy ) LR probabilities on health status is largely lost. (2) and (3) have the same form, i.e. LR is symmetric with respect to disease status. This symmetric form is not biologically plausible considering causality of diseases. Specifically, a common concept is that one may get the disease if any one of the risk factors are penetrant or active, whereas being healthy requires all of the factors to be inactive. This conceptual model is inherently asymmetric with respect to the two health statuses, diseased and healthy. In contrast, LR makes no distinction in mathematically defining diseased or healthy subjects.
LR limitations. Note that
Moreover, LR is invalid in the presence of many common confounders in practice. Because the prevailing scenario regarding complex diseases is that we often have incomplete knowledge of the true risk factors, the major confounders include missing/unmeasured factors and imperfect surrogates. We have shown that the LR parametric form is not invariant to these two effects and there is no way to "correct" LR for these potentially confounding effects in practice. For example, suppose there are three binary causal factors; when all three factors are observed we have model LR-3; Suppose now that the third risk factor is missing. If LR is invariant to missing factors, then marginalizing out the third risk factor from LR-3 should yield a model with the LR parametric form based on the two remaining risk factors. However, it is shown that the marginalized model does not have the LR parametric form (Fig. 1c and Appendix B) . In a similar fashion, also by counterexample, we have shown that the prediction of health status by LR is not invariant to imperfect surrogates. In conclusion, in the presence of these common confounders, LR is theoretically biased which, as will be shown experimentally in this report, results in either inflated type 1 error or reduced power or both (Appendix D-E).
Asymmetric independence model. In developing the AIM null hypothesis model, we assume that risk factors independently exert effects on health status, expressed mathematically as
where ∈ c {0/healthy, 1/diseased} i is the latent 'local' disease status random variable coupled to each factor x i , i.e., with the c i assumed statistically independent of each other given the status of x i . We also assume that the factor being active is required for the local status to be 'diseased' , i.e.,
; on the other hand, the active factor probabilistically causes the local status to be "diseased" based on the conditional probability φ = = | = P c x ( 1 1 )
. As one example, in one of the two esophageal cancer studies, there are two binary factors, x 1 and x 2, representing presence/absence of smoking and alcohol consumption, respectively. Each of these factors is coupled to a local disease status variable, c i , = i 1, 2. The probability
is the propensity for disease ( = c 1 1 ) given that an individual is a smoker. Likewise, there is a propensity for disease given that the individual is an alcohol consumer,
. We further assume that an overall healthy status occurs only if every active factor does not cause its local status to be 'diseased' , expressed mathematically as
where c 0 is a 'background' status accounting for sporadic disease occurrence that cannot be explained by any active factor, with probability φ = = P c 
i
where the regression coefficient can be explicitly interpreted as the logarithm of the local healthy probability, i.e.,
. Because mechanisms of being healthy and diseased are different, in contrast to LR, AIM is specifically formulated to be asymmetric with respect to disease status, with the log-probability of being healthy a linear function of the factors (6) whereas the log-probability of being diseased is clearly nonlinear (7) . Furthermore, AIM is supported by several well-accepted biological models, including the heterogeneity theory 10 and the two-hits theory of cancer 11 (Appendix C.4). While we have argued that AIM is more biologically plausible than LR, we believe the most compelling support for AIM comes from the invariance of this model, unlike LR, in the presence of common confounders such as missing factors, imperfect surrogates, and disease heterogeneity. We emphasize that no modifications of the model given in (6) and (7) are needed to achieve AIM's invariance to these confounders. The mathematical proofs of AIM's invariance to these common confounders are given in (Appendix C.5-7). We also point out that, similar to the logistic regression model, AIM can readily account for covariate effects, if observed, by including extra terms corresponding to these covariate factors. Lastly, we have shown that maximum likelihood estimation of the AIM model is a convex optimization problem and we have developed an efficient learning algorithm (Appendix C.2-3).
Likelihood function for AIM. Consider a case-control population
where x i is the factor vector for the i-th subject and = I 1 i for a case and
The likelihood of X under the AIM model is:
, with the log-likelihood given by:
. This is a convex function of the parameter vector b (Appendix C.2) with the resulting maximum likelihood estimation (MLE) learning problem a convex optimization problem, amenable to finding the global maximum.
Likelihood ratio test for AIM. Given a case-control population X, one performs MLE to learn the AIM null hypothesis model (no interaction), with log-likelihood
. To test for an interaction between factors x i and x j one adds an interaction term of the form β x x ij i j to the AIM posterior in equations (6) and (7) Detecting interaction in venous thrombosis dataset. The interaction between thrombophilic mutations and oral contraceptive is well-established, with multiple epidemiological and mechanical studies 14, 15, 23, 24 . In the Legnani et al. study, the odds ratio associated with the use of oral contraceptive but no thrombophilic genetic risk mutation is 1.95, and the odds ratio associated with genetic defects but no use of contraceptive is 4.79. There is strong evidence of interaction. Indeed, by applying LR, we get a p-value of 0.021, which is statistically significant. There are 947 subjects in the Legnani et al. study. When all the frequencies of the risk factors and the effect size are kept the same, we estimate that, to achieve the 0.05 significance level, LR requires 676 subjects, while AIM needs only 303 subjects. For the Martinelli et al. study, the odds ratio associated with the presence of both risk factors is expected to be 11.9, compared to the observed value of 18.1. Both studies have the same effect direction, that is, the observed odds ratio is larger than the expectation. Due to the limited sample size, the conclusion is not statistically significant in the Martinelli et al. study. The p-value generated by LR is 0.618 and the p-value obtained from AIM is 0.183. To achieve the 0.05 significance level, the estimated sample size associated with LR is 4391, while AIM requires just 614 subjects.
Detecting smoking-alcohol interaction in esophageal cancer dataset. The data are divided into three groups -males, females, and all subjects. In each group, we calculate the interaction effect based on LR and AIM. We can see that the new model consistently generates smaller p-values than LR. In the males group, the p-value is 5.43e-6 based on the new model, while it is 0.81 for LR and far from being considered significant. We also estimate the sample sizes required for the two models to achieve the 0.05 significance level, again assuming that all the frequencies of the risk factors and the effect size are kept the same. In the males group, LR needs
